CLLS
Income statement / Annual
Last year (2023), Cellectis S.A.'s total revenue was $755,000.00,
a decrease of 96.06% from the previous year.
In 2023, Cellectis S.A.'s net income was -$101.06 M.
See Cellectis S.A.�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$755,000.00
|
$19.17 M
|
$73.95 M
|
$73.95 M
|
$15.19 M
|
$12.73 M
|
$25.19 M
|
$42.58 M
|
$55.04 M
|
$26.30 M
|
| Cost of Revenue |
$737,000.00 |
$1.77 M |
$36.28 M |
$36.28 M |
$11.39 M |
$2.74 M |
$2.62 M |
$1.69 M |
$2.71 M |
$3.69 M |
| Gross Profit |
$18,000.00 |
$17.40 M |
$37.67 M |
$37.67 M |
$3.80 M |
$9.99 M |
$22.57 M |
$40.90 M |
$52.34 M |
$22.61 M |
| Gross Profit Ratio |
0.02 |
0.91 |
0.51 |
0.51 |
0.25 |
0.78 |
0.9 |
0.96 |
0.95 |
0.86 |
| Research and Development
Expenses |
$87.65 M
|
$97.50 M
|
$86.95 M
|
$86.95 M
|
$92.04 M
|
$76.57 M
|
$79.23 M
|
$74.56 M
|
$57.30 M
|
$17.52 M
|
| General & Administrative
Expenses |
$16.81 M
|
$17.49 M
|
$37.87 M
|
$44.20 M
|
$43.02 M
|
$47.25 M
|
$44.75 M
|
$41.26 M
|
$29.78 M
|
$15.95 M
|
| Selling & Marketing
Expenses |
$0.00
|
$3.11 M
|
$6.33 M
|
$1.66 M
|
$11.43 M
|
$16.69 M
|
$9.14 M
|
$8.41 M
|
$6.67 M
|
$6.57 M
|
| Selling, General &
Administrative Expenses |
$16.81 M
|
$17.49 M
|
$44.20 M
|
$44.20 M
|
$43.02 M
|
$47.25 M
|
$44.75 M
|
$41.26 M
|
$29.78 M
|
$15.95 M
|
| Other Expenses |
-$7.14 M |
-$7.93 M |
-$8.04 M |
-$8.04 M |
-$7.71 M |
-$25.42 M |
-$17.90 M |
-$19.38 M |
-$10.88 M |
-$11.05 M |
| Operating Expenses |
$97.32 M |
$107.07 M |
$123.11 M |
$123.11 M |
$127.35 M |
$115.08 M |
$115.22 M |
$104.86 M |
$82.87 M |
$28.98 M |
| Cost And Expenses |
$98.06 M |
$108.84 M |
$159.39 M |
$159.39 M |
$138.74 M |
$117.82 M |
$117.84 M |
$106.54 M |
$85.57 M |
$32.68 M |
| Interest Income |
$3.61 M |
$1.12 M |
$736,000.00 |
$1.95 M |
$8.34 M |
$16.76 M |
$1.97 M |
$44,171.00 |
$8.25 M |
$384,259.00 |
| Interest Expense |
$6.43 M |
$3.79 M |
$5.34 M |
$12.05 M |
$2.61 M |
$46,000.00 |
$4,000.00 |
$6,310.21 |
$22,959.00 |
$195,778.00 |
| Depreciation &
Amortization |
$18.52 M
|
$18.44 M
|
$14.16 M
|
$9.82 M
|
$6.88 M
|
$2.38 M
|
$3.37 M
|
$2.21 M
|
$1.91 M
|
$1.67 M
|
| EBITDA |
-$92.64 M
|
-$76.38 M
|
-$86.46 M
|
-$34.68 M
|
-$105.09 M
|
-$93.79 M
|
-$108.08 M
|
-$65.32 M
|
-$26.21 M
|
$370,080.00
|
| EBITDA Ratio |
-122.7 |
-4.68 |
-1.16 |
-1.16 |
-8.13 |
-8.25 |
-3.68 |
-1.5 |
-0.52 |
-0.17 |
| Operating Income Ratio
|
-141.23
|
-4.68
|
-1.16
|
-1.16
|
-8.13
|
-8.25
|
-3.68
|
-1.5
|
-0.55
|
-0.24
|
| Total Other
Income/Expenses Net |
-$16.42 M
|
-$8.94 M
|
$6.73 M
|
-$12.05 M
|
$8.34 M
|
$16.76 M
|
-$11.03 M
|
$47,000.00
|
$8.38 M
|
$8.63 M
|
| Income Before Tax |
-$123.05 M |
-$98.60 M |
-$97.48 M |
-$97.48 M |
-$115.21 M |
-$88.33 M |
-$103.68 M |
-$63.92 M |
-$22.27 M |
$2.25 M |
| Income Before Tax Ratio
|
-162.97
|
-5.14
|
-1.32
|
-1.32
|
-7.58
|
-6.94
|
-4.12
|
-1.5
|
-0.4
|
0.09
|
| Income Tax Expense |
-$6.21 M |
$87,000.00 |
-$11.20 M |
-$24.91 M |
-$24.53 M |
$16.81 M |
-$13.20 M |
-$1.54 M |
-$926,027.16 |
$2.42 M |
| Net Income |
-$101.06 M |
-$98.69 M |
-$86.28 M |
-$72.57 M |
-$90.69 M |
-$78.69 M |
-$99.37 M |
-$63.92 M |
-$22.46 M |
$24,320.00 |
| Net Income Ratio |
-133.85 |
-5.15 |
-1.17 |
-0.98 |
-5.97 |
-6.18 |
-3.95 |
-1.5 |
-0.41 |
0 |
| EPS |
-1.77 |
-2.17 |
-1.93 |
-1.71 |
-2.14 |
-1.93 |
-2.78 |
-1.81 |
-0.66 |
0.0009 |
| EPS Diluted |
-1.77 |
-2.17 |
-1.93 |
-1.71 |
-2.14 |
-1.93 |
-2.78 |
-1.78 |
-0.65 |
0.0009 |
| Weighted Average Shares
Out |
$57.01 M
|
$45.55 M
|
$44.82 M
|
$42.50 M
|
$42.44 M
|
$40.77 M
|
$35.69 M
|
$35.29 M
|
$34.15 M
|
$26.07 M
|
| Weighted Average Shares
Out Diluted |
$57.01 M
|
$45.55 M
|
$44.82 M
|
$42.50 M
|
$42.44 M
|
$40.77 M
|
$35.69 M
|
$35.81 M
|
$34.52 M
|
$26.19 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
